Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;133(11):1313-1321.e6.
doi: 10.1016/j.amjmed.2020.03.058. Epub 2020 May 19.

Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team

Affiliations

Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team

Brett J Carroll et al. Am J Med. 2020 Nov.

Abstract

Background: Optimal management of acute pulmonary embolism requires expertise offered by multiple subspecialties. As such, pulmonary embolism response teams (PERTs) have increased in prevalence, but the institutional consequences of a PERT are unclear.

Methods: We compared all patients that presented to our institution with an acute pulmonary embolism in the 3 years prior to and 3 years after the formation of our PERT. The primary outcome was in-hospital pulmonary embolism-related mortality before and after the formation of the PERT. Sub-analyses were performed among patients with elevated-risk pulmonary embolism.

Results: Between August 2012 and August 2018, 2042 patients were hospitalized at our institution with acute pulmonary embolism, 884 (41.3%) pre-PERT implementation and 1158 (56.7%) post-PERT implementation, of which 165 (14.2%) were evaluated by the PERT. There was no difference in pulmonary embolism-related mortality between the two time periods (2.6% pre-PERT implementation vs 2.9% post-PERT implementation, P = .89). There was increased risk stratification assessment by measurement of cardiac biomarkers and echocardiograms post-PERT implementation. Overall utilization of advanced therapy was similar between groups (5.4% pre-PERT implementation vs 5.4% post-PERT implementation, P = 1.0), with decreased use of systemic thrombolysis (3.8% pre-PERT implementation vs 2.1% post-PERT implementation, P = 0.02) and increased catheter-directed therapy (1.3% pre-PERT implementation vs 3.3% post-PERT implementation, P = 0.05) post-PERT implementation. Inferior vena cava filter use decreased after PERT implementation (10.7% pre-PERT implementation vs 6.9% post-PERT implementation, P = 0.002). Findings were similar when analyzing elevated-risk patients.

Conclusion: Pulmonary embolism response teams may increase risk stratification assessment and alter application of advanced therapies, but a mortality benefit was not identified.

Keywords: Catheter-directed thrombolysis; Inferior vena cava filters, Pulmonary embolism, Response teams, Systemic thrombolysis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: DSP is a consultant for Abbott Vascular, Abiomed, Boston Scientific, Medtronic, NuPulseCV, and Teleflex. KAB has served as a consultant for Bristol Myers Squibb. EAS has received research grants to BIDMC: AstraZeneca, BD Bard, Boston Scientific, Cook Medical, CSI, Medtronic, Philips, and the University of California, San Francisco; is a consultant for BD Bard, CSI, Janssen, Medtronic, and Philips; and is on the speaking bureau for BD Bard, Cook Medical, and Medtronic. The remaining authors have no relevant disclosures.

Figures

Figure 1
Figure 1
Outcomes in all patients admitted with an acute pulmonary embolism before and after PERT implementation. IVC = inferior vena cava; PERT = pulmonary embolism response team.
Figure 2
Figure 2
Outcomes in elevated-risk patients with an acute pulmonary embolism before and after PERT implementation. IVC = inferior vena cava; PERT = pulmonary embolism response team.

Similar articles

Cited by

References

    1. Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2020;41:522–9. - PubMed
    1. Bikdeli B, Wang Y, Jimenez D, et al. Pulmonary embolism hospitalization, readmission, and mortality rates in US older adults, 1999–2015. JAMA. 2019;322:574–6. - PMC - PubMed
    1. Secemsky E, Chang Y, Jain CC, et al. Contemporary management and outcomes of patients with massive and submassive pulmonary embolism. Am J Med. 2018;131:1506–14. - PubMed
    1. Raskob GE, van Es N, Verhamme P, et al. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Eng J Med. 2018;378:615–24. - PubMed
    1. Piazza G, Hohlfelder B, Jaff MR, et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv. 2015;8:1382–92. - PubMed

MeSH terms

Substances